Advanced company searchLink opens in new window

CENTESSA PHARMACEUTICALS (OREXIA) LIMITED

Company number 11607013

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
12 Feb 2021 TM01 Termination of appointment of Mario Alberto Accardi as a director on 29 January 2021
12 Feb 2021 PSC02 Notification of United Medicines Biopharma Limited as a person with significant control on 29 January 2021
12 Feb 2021 TM01 Termination of appointment of Francesco De Rubertis as a director on 29 January 2021
12 Feb 2021 PSC09 Withdrawal of a person with significant control statement on 12 February 2021
04 Dec 2020 CS01 Confirmation statement made on 3 December 2020 with updates
10 Nov 2020 SH01 Statement of capital following an allotment of shares on 2 November 2020
  • EUR 608.0131
06 Nov 2020 AP01 Appointment of Dr Emiliangelo Ratti Ratti as a director on 2 November 2020
15 Oct 2020 CS01 Confirmation statement made on 4 October 2020 with updates
03 Jul 2020 AA Accounts for a small company made up to 31 December 2019
11 Mar 2020 SH01 Statement of capital following an allotment of shares on 5 March 2020
  • EUR 598.1058
07 Jan 2020 RESOLUTIONS Resolutions
  • RES03 ‐ Resolution of exemption from the Appointing of Auditors
14 Nov 2019 SH01 Statement of capital following an allotment of shares on 2 November 2019
  • EUR 597.5059
14 Oct 2019 CS01 Confirmation statement made on 4 October 2019 with updates
13 Sep 2019 CH01 Director's details changed for Dr Mario Alberto Accardi on 12 September 2019
20 Aug 2019 SH01 Statement of capital following an allotment of shares on 7 August 2019
  • EUR 596.906
19 Aug 2019 SH01 Statement of capital following an allotment of shares on 7 August 2019
  • EUR 596.906
10 May 2019 AP01 Appointment of Mr Remy Henri Luthringer as a director on 16 April 2019
13 Mar 2019 SH01 Statement of capital following an allotment of shares on 7 March 2019
  • EUR 593.9065
30 Jan 2019 SH01 Statement of capital following an allotment of shares on 21 January 2019
  • EUR 590.907
15 Jan 2019 SH08 Change of share class name or designation
14 Jan 2019 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
03 Jan 2019 AA01 Current accounting period extended from 31 October 2019 to 31 December 2019
03 Jan 2019 AP01 Appointment of Dr Mario Alberto Accardi as a director on 2 January 2019
05 Oct 2018 NEWINC Incorporation
Statement of capital on 2018-10-05
  • EUR .0001